These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24332492)
1. Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities. Singh P; Shaveta ; Sharma S; Bhatti R Bioorg Med Chem Lett; 2014 Jan; 24(1):77-82. PubMed ID: 24332492 [TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug. Shaveta ; Singh A; Kaur M; Sharma S; Bhatti R; Singh P Eur J Med Chem; 2014 Apr; 77():185-92. PubMed ID: 24631898 [TBL] [Abstract][Full Text] [Related]
3. Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors. Mohamed LW; El-Badry OM; El-Ansary AK; Ismael A Bioorg Chem; 2017 Jun; 72():308-314. PubMed ID: 28500957 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach. Banerjee AG; Das N; Shengule SA; Sharma PA; Srivastava RS; Shrivastava SK Bioorg Chem; 2016 Dec; 69():102-120. PubMed ID: 27750057 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship. Hayashi S; Sumi Y; Ueno N; Murase A; Takada J Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives. Abdellatif KR; Fadaly WA; Ali WA; Kamel GM J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738 [TBL] [Abstract][Full Text] [Related]
7. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165 [TBL] [Abstract][Full Text] [Related]
8. Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites. Ju Z; Su M; Hong J; La Kim E; Moon HR; Chung HY; Kim S; Jung JH Eur J Med Chem; 2019 Oct; 180():86-98. PubMed ID: 31301566 [TBL] [Abstract][Full Text] [Related]
9. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695 [TBL] [Abstract][Full Text] [Related]
10. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole. Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY. Abdelall EKA; Lamie PF; Ali WAM Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking design and one-pot expeditious synthesis of novel 2,5-diarylpyrazolo[1,5-a]pyrimidin-7-amines as anti-inflammatory agents. Aggarwal R; Singh G; Kaushik P; Kaushik D; Paliwal D; Kumar A Eur J Med Chem; 2015 Aug; 101():326-33. PubMed ID: 26160113 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of loxoprofen derivatives. Yamakawa N; Suemasu S; Matoyama M; Tanaka K; Katsu T; Miyata K; Okamoto Y; Otsuka M; Mizushima T Bioorg Med Chem; 2011 Jun; 19(11):3299-311. PubMed ID: 21570308 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of phenylpiperazine derivatives of 1,4-benzodioxan as selective COX-2 inhibitors and anti-inflammatory agents. Sun J; Wang S; Sheng GH; Lian ZM; Liu HY; Zhu HL Bioorg Med Chem; 2016 Nov; 24(21):5626-5632. PubMed ID: 27658794 [TBL] [Abstract][Full Text] [Related]
18. Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Alanazi AM; El-Azab AS; Al-Suwaidan IA; ElTahir KE; Asiri YA; Abdel-Aziz NI; Abdel-Aziz AA Eur J Med Chem; 2015 Mar; 92():115-23. PubMed ID: 25549551 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Dawood KM; Abdel-Gawad H; Rageb EA; Ellithey M; Mohamed HA Bioorg Med Chem; 2006 Jun; 14(11):3672-80. PubMed ID: 16464601 [TBL] [Abstract][Full Text] [Related]
20. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors. Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]